Pierre Fabre (France)

Recent papers from Pierre Fabre (France)

1. Therapeutic Education in Atopic Dermatitis Worldwide: Current Practices and Future Pathways—An Update From the Oriented Patient Education Network of the International Society of Atopic Dermatitis (OpenED‐ISAD)JEADV Clinical Practice · 2026
2. Beyond the Operating Room: Ultrasound-Guided Tibial Nerve Block for Plantar Wound Care in a Desert UltramarathonWilderness and Environmental Medicine · 2026
3. A phase I, dose-escalation study of weekly vinflunine in patients with advanced solid tumoursAcademia oncology. · 2026
4. The Role of General Practitioners in Actinic Keratosis Management in Europe: A Dermato-Oncologists InitiativeJournal of Clinical Medicine · 2026
5. Impact of design, size, and a combined routine on the plaque removal efficacy of manual, hybrid (powered-mode) and interdental toothbrushes: a robot-assisted in vitro studyBMC Oral Health · 2026
6. A phase 2 study of encorafenib in combination with binimetinib for Chinese participants with BRAFV600E mutated metastatic non-small cell lung cancer: Results from the OCEAN II studyLung Cancer · 2026
7. Bayesian Estimation of the Binomial Parameter in Adaptive Designs With Treatment SelectionStatistics in Medicine · 2026
8. primary analysis of the RANDOMIZED eortc-2139/columbus-ad trial: Adjuvant encorafenib and binimetinib versus placebo in high-risk stage II BRAF-V600E/K melanomaEuropean Journal of Cancer · 2026
9. Downregulation of the calcium current in human right atrial myocytes from patients in sinus rhythm but with a high risk of atrial fibrillationEuropean Heart Journal · 2008
10. Between evidence and experience: a sociocultural analysis of learning and practice in anterior cruciate ligament rehabilitationBMC Medical Education · 2026
11. Triceps Surae Neuromuscular Activity During Single-leg Jumping Tasks in Individuals After Anterior Cruciate Ligament ReconstructionInternational Journal of Sports Physical Therapy · 2026
12. Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing OutcomesDermatology and Therapy · 2026
13. A novel CD7-directed antibody-drug conjugate targeting BCL-XL with potent anti-leukemic activity in T-cell acute lymphoblastic leukemiaLeukemia · 2026
14. Results from OCEAN II: A phase II study of encorafenib + binimetinib combination in Chinese patients with BRAF V600E mutated metastatic non-small cell lung cancer.Journal of Clinical Oncology · 2026
15. First-in-human dose-escalation study of the selective EGFR/HER2 exon 20 inhibitor PFL-721 in patients with locally advanced or metastatic NSCLC.Journal of Clinical Oncology · 2026
16. Synthesis and Vibrational Identification of the Uranyl Peroxodicarbonato [UO2(O2)(CO3)2]4-: Insights into Peroxide-Carbonate Bonding from 18O Labeling, DFT and QTAIM analysis2026
17. Remote Sophrology in Congenital Heart Disease: The SOPHROCARE Randomized Controlled Trial.2026
18. Turning precision medicine into reality with statistics and data-driven decision making across pharmaceutical developmentCommunications Medicine · 2026
19. Lipidomic Insights into Seborrheic Dermatitis: Clinical Evaluation of Sebum Changes Using SpiderMassDermatology and Therapy · 2026
20. A Randomized Trial of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or FOLFIRI /Cetuximab in Chinese Patients With BRAF V600E Mutant Metastatic Colorectal Cancer: The NAUTICAL StudyCancer Medicine · 2026